Block Copolymer Biologic Carriers With Low-Toxicity Nucleic Acid Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nanoparticle delivery systems for biologics face challenges such as cytotoxicity, instability under physiological conditions, immune response, and limited targeting capabilities, leading to inefficient and potentially harmful delivery of nucleic acids and other biologics.
Innovation Solution
A polymeric delivery system using a block copolymer of a polyester copolymer of a polyol and a polycarboxylic acid, which forms self-assembled particles that are non-immunogenic, tunable for specific degradation kinetics, and decorated with functional moieties for targeted delivery, enhancing stability and biocompatibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cationic polymers are used to deliver nucleic acids, then condensation efficiency and nuclease protection are improved, but cellular toxicity increases
Solution Approach 1:
The patent modifies the polymer structure by controlling the degree of quaternization (molar ratio of alkylating agent to amine groups) to adjust the balance between positive charge density for nucleic acid binding and reduced toxicity. By optimizing this parameter, the system maintains effective condensation while minimizing cellular damage
Solution Approach 2:
The invention uses copolymers containing both cationic (amine-containing) and non-cationic (hydrocarbon-containing) monomer units. This composite structure allows the cationic portions to bind nucleic acids effectively while the non-cationic portions reduce overall toxicity, achieving a balance between delivery efficiency and biocompatibility
2Adaptability or versatility
If nanoparticle delivery systems are used, then targeted delivery is improved, but immune response and inflammatory reactions increase
Solution Approach 1:
The patent optimizes nanoparticle size parameters (average diameter of 50-200 nm) and surface charge characteristics to enhance cellular uptake and targeting while minimizing recognition by the reticuloendothelial system. By carefully controlling these physical parameters, the system achieves effective delivery without triggering strong immune responses
Solution Approach 2:
The invention introduces functional moieties at specific locations on the nanoparticle surface (such as targeting ligands attached to polymer chains) rather than uniformly modifying the entire particle. This localized functionalization enables specific targeting capabilities while keeping other surface regions inert to reduce immune recognition
3Device complexity
If conventional polymers are used for delivery, then formulation simplicity is maintained, but biocompatibility and biodegradability are insufficient
Solution Approach 1:
The patent employs copolymers with both cationic and non-cationic monomer units, creating a composite material that combines the desirable properties of each component. The cationic units provide nucleic acid binding capability while the non-cationic hydrocarbon units improve biocompatibility and controlled biodegradability, achieving enhanced performance without significantly complicating the formulation approach
4Reliability
If high concentration of cationic polymers is used, then nucleic acid condensation is improved, but cytotoxicity increases
Solution Approach 1:
The invention uses copolymers where non-cationic hydrocarbon-containing units dilute the overall charge density while maintaining sufficient cationic sites for effective condensation. This composite structure allows achieving good condensation efficiency at lower polymer concentrations, thereby reducing cytotoxicity
Solution Approach 2:
The patent optimizes the molecular weight and degree of polymerization to achieve effective condensation at lower concentrations. By controlling these parameters, the system maintains nucleic acid complexation efficiency while reducing the total amount of polymer required, thus minimizing toxic effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides improved nanoparticle stability, increased blood residency time, reduced cellular stress, and targeted delivery of biologics with minimal inflammatory response, overcoming the limitations of conventional systems.
Implementation Method 1
The block copolymers self assemble in aqueous environments to form nanoparticles
Implementation Method 2
a first block of a polyester copolymer of a polyol and a polycarboxylic acid
Data Source
AI summary
A polymeric delivery system delivers a biologic to cells. In some embodiments, the polymeric delivery system includes polyplexes. Each polyplex includes at least one charged polymer and at least one biologic. The at least one charged polymer includes a polyester copolymer of a polyol and a polycarboxylic acid modified with at least one charged moiety having an opposite charge from a net charge of the at least one biologic. In other embodiments, the polymeric delivery system includes self-assembled particles including a block copolymer and a biologic associated with the block copolymer. The block copolymer includes a first block of a polyester copolymer of a polyol and a polycarboxylic acid and a second block of a second monomer or a second polymer.